Comparing chemoradiation timing for mid-low rectal cancer
Part of Cancer, Digestive system clinical trials.
This trial compares two treatment approaches for stage II or III mid-low rectal cancer: giving chemoradiation after surgery or before surgery. It aims to find out which sequence leads to better outcomes for patients without certain high-risk features.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have adenocarcinoma (the most common type) of the middle or lower rectum, confirmed by a biopsy.
- The lower edge of the tumor is within 10 centimeters of the anal opening.
- You are well enough to go about daily activities (ECOG score 0, 1, or 2).
- You have not had chemotherapy or radiation for this cancer before, and the cancer has not spread to distant organs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatment approaches for stage II (T3) rectal cancer: chemoradiation before surgery versus a total neoadjuvant therapy approach (chemotherapy and radiation) before surgery. It aims to find which is more effective and safer.
This Phase 3 trial compares different chemotherapy and radiation combinations given before surgery for locally advanced rectal cancer, to see which one works better. It may help people get a tumor removed completely (R0 resection) and improve outcomes while comparing treatment safety and effectiveness.
This Phase 3 trial compares two treatment plans given before rectal surgery. It tests whether stronger chemotherapy alone works better than chemotherapy pills plus long-term radiation to improve outcomes for locally advanced rectal cancer.
This Phase 3 study tests whether giving chemotherapy before rectal surgery can work as well as standard treatment that usually includes pelvic radiation. It aims to reduce the need for pelvic radiation while still keeping the cancer under control.
This study tests a sequence of chemotherapy and radiation before and after surgery for rectal cancer. It compares giving more chemo between the end of radiation and surgery (consolidation) versus giving some chemo before radiation starts (induction). The goal is to see which order works better.
This trial compares two different schedules of radiation therapy given before surgery for advanced rectal cancer. The goal is to find out if a shorter course of radiation works as well as the longer course, with fewer side effects.
Hear when a new Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.